These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 18000086

  • 21. Dose-dependent effect of rosuvastatin on apolipoprotein B-100 kinetics in the metabolic syndrome.
    Ooi EM, Barrett PH, Chan DC, Nestel PJ, Watts GF.
    Atherosclerosis; 2008 Mar; 197(1):139-46. PubMed ID: 17416370
    [Abstract] [Full Text] [Related]

  • 22. Effect of fasting and feeding on apolipoprotein A-I kinetics in preβ1-HDL, α-HDL, and triglyceride-rich lipoproteins.
    Chétiveaux M, Croyal M, Ouguerram K, Fall F, Flet L, Zair Y, Nobecourt E, Krempf M.
    Sci Rep; 2020 Sep 24; 10(1):15585. PubMed ID: 32973209
    [Abstract] [Full Text] [Related]

  • 23. Effect of an isoenergetic traditional Mediterranean diet on apolipoprotein A-I kinetic in men with metabolic syndrome.
    Richard C, Couture P, Desroches S, Lichtenstein AH, Lamarche B.
    Nutr J; 2013 Jun 07; 12(1):76. PubMed ID: 24499022
    [Abstract] [Full Text] [Related]

  • 24. High-density lipoprotein apolipoprotein A-I kinetics in obesity.
    Ooi EM, Watts GF, Farvid MS, Chan DC, Allen MC, Zilko SR, Barrett PH.
    Obes Res; 2005 Jun 07; 13(6):1008-16. PubMed ID: 15976143
    [Abstract] [Full Text] [Related]

  • 25. Interrelationships between the kinetics of VLDL subspecies and HDL catabolism in abdominal obesity: a multicenter tracer kinetic study.
    Vergès B, Adiels M, Boren J, Barrett PH, Watts GF, Chan D, Duvillard L, Söderlund S, Matikainen N, Kahri J, Robin I, Taskinen MR.
    J Clin Endocrinol Metab; 2014 Nov 07; 99(11):4281-90. PubMed ID: 25077901
    [Abstract] [Full Text] [Related]

  • 26. Apolipoprotein C-III and its defined lipoprotein subspecies in relation to incident diabetes: the Multi-Ethnic Study of Atherosclerosis.
    Aroner SA, Furtado JD, Sacks FM, Tsai MY, Mukamal KJ, McClelland RL, Jensen MK.
    Diabetologia; 2019 Jun 07; 62(6):981-992. PubMed ID: 30949716
    [Abstract] [Full Text] [Related]

  • 27. Metabolism of apolipoprotein A-II containing triglyceride rich ApoB lipoproteins in humans.
    Desai NK, Ooi EM, Mitchell PD, Furtado J, Sacks FM.
    Atherosclerosis; 2015 Aug 07; 241(2):326-33. PubMed ID: 26071654
    [Abstract] [Full Text] [Related]

  • 28. Combining beta-adrenergic and peroxisome proliferator-activated receptor gamma stimulation improves lipoprotein composition in healthy moderately obese subjects.
    Hughes TA, Stentz F, Gettys T, Smith SR.
    Metabolism; 2006 Jan 07; 55(1):26-34. PubMed ID: 16324916
    [Abstract] [Full Text] [Related]

  • 29. Obesity favors apolipoprotein E- and C-III-containing high density lipoprotein subfractions associated with risk of heart disease.
    Talayero B, Wang L, Furtado J, Carey VJ, Bray GA, Sacks FM.
    J Lipid Res; 2014 Oct 07; 55(10):2167-77. PubMed ID: 24966274
    [Abstract] [Full Text] [Related]

  • 30. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J, Escolà-Gil JC, Rotllan N, Fiévet C, Vallez E, de la Torre C, Ribas V, Sloan JH, Blanco-Vaca F.
    Arterioscler Thromb Vasc Biol; 2010 Feb 07; 30(2):232-8. PubMed ID: 19910634
    [Abstract] [Full Text] [Related]

  • 31. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C, Tremblay M, Fredenrich A, Davignon J, Cohn JS.
    Metabolism; 2001 Jan 07; 50(1):112-9. PubMed ID: 11172484
    [Abstract] [Full Text] [Related]

  • 32. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity.
    Riches FM, Watts GF, Naoumova RP, Kelly JM, Croft KD, Thompson GR.
    Int J Obes Relat Metab Disord; 1998 May 07; 22(5):414-23. PubMed ID: 9622338
    [Abstract] [Full Text] [Related]

  • 33. Apolipoprotein E in VLDL and LDL with apolipoprotein C-III is associated with a lower risk of coronary heart disease.
    Mendivil CO, Rimm EB, Furtado J, Sacks FM.
    J Am Heart Assoc; 2013 May 14; 2(3):e000130. PubMed ID: 23672999
    [Abstract] [Full Text] [Related]

  • 34. Apolipoprotein B-100 kinetics and static plasma indices of triglyceride-rich lipoprotein metabolism in overweight men.
    Chan DC, Watts GF, Ng TW, Uchida Y, Sakai N, Yamashita S, Barrett PH.
    Clin Biochem; 2005 Sep 14; 38(9):806-12. PubMed ID: 15992790
    [Abstract] [Full Text] [Related]

  • 35. Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans: in vivo evidence for a link between HDL apoC-III and apoA-I metabolism.
    Cohn JS, Batal R, Tremblay M, Jacques H, Veilleux L, Rodriguez C, Mamer O, Davignon J.
    J Lipid Res; 2003 Oct 14; 44(10):1976-83. PubMed ID: 12867543
    [Abstract] [Full Text] [Related]

  • 36. In-vivo metabolism of VLDL-apolipoprotein-B, -CIII and -E in normolipidemic subjects.
    Dinkel RE, Barrett PH, Demant T, Parhofer KG.
    Nutr Metab Cardiovasc Dis; 2006 Apr 14; 16(3):215-21. PubMed ID: 16580589
    [Abstract] [Full Text] [Related]

  • 37. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status.
    Matthan NR, Jalbert SM, Lamon-Fava S, Dolnikowski GG, Welty FK, Barrett HR, Schaefer EJ, Lichtenstein AH.
    Arterioscler Thromb Vasc Biol; 2005 Aug 14; 25(8):1691-6. PubMed ID: 15933247
    [Abstract] [Full Text] [Related]

  • 38. Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women.
    Wassef H, Bissonnette S, Dufour R, Davignon J, Faraj M.
    J Nutr; 2017 May 14; 147(5):754-762. PubMed ID: 28356429
    [Abstract] [Full Text] [Related]

  • 39. High density lipoprotein with apolipoprotein C-III is associated with carotid intima-media thickness among generally healthy individuals.
    Yamamoto R, Sacks FM, Hu FB, Rosner B, Furtado JD, Aroner SA, Ferrannini E, Baldi S, Kozakova M, Balkau B, Natali A, Jensen MK, RISC Investigators.
    Atherosclerosis; 2018 Feb 14; 269():92-99. PubMed ID: 29351856
    [Abstract] [Full Text] [Related]

  • 40. Association of apolipoprotein M with high-density lipoprotein kinetics in overweight-obese men.
    Ooi EM, Watts GF, Chan DC, Nielsen LB, Plomgaard P, Dahlbäck B, Barrett PH.
    Atherosclerosis; 2010 May 14; 210(1):326-30. PubMed ID: 20031132
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.